Fighting vampires and ventilator-associated pneumonia: Is silver the magic bullet?

Chest

Volumn 137, Issue 5, 2010, Pages 1007-1009

  Niederman, Michael S ^a,b  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; SILVER;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BIOFILM; CENTRAL VENOUS CATHETER; DISEASE SEVERITY; DISPERSION; EDITORIAL; ENDOTRACHEAL TUBE; HUMAN; INFECTION CONTROL; INFECTION RISK; INTENSIVE CARE UNIT; LENGTH OF STAY; MATERIAL COATING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY FAILURE; RISK REDUCTION; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 77951800384     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-0063     Document Type: Editorial

References (15)

1. Rello J, Kollef M, Diaz E, et al. Reduced burden of bacterial airway colonization with a novel silver-coated endotracheal tube in a randomized multiple-center feasibility study. Crit Care Med. 2006;34(11):2766-2772. (Pubitemid 44610941)
2. Kollef MH, Afessa B, Anzueto A, et al; NASCENT Investigation Group. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA. 2008;300(7):805-813.
3. Chastre J. Preventing ventilator-associated pneumonia: could silver-coated endotracheal tubes be the answer? JAMA. 2008;300(7):842-844.
4. Afessa B, Shorr AF, Anzueto A, Craven DE, Schinner R, Kollef MH. Association between a silver-coated endotracheal tube and reduced mortality in patients with ventilator-associated pneumonia. Chest. 2010;137(5):1015-1021.
5. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C; The Canadian Critical Trials Group. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Respir Crit Care Med. 1999;159(4 pt 1):1249-1256.
6. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med. 2005;33(10):2184-2193. (Pubitemid 41437469)
7. Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest. 1997;111(3):676-685. (Pubitemid 27132946)
8. Rello J, Jubert P, Vallés J, Artigas A, Rué M, Niederman MS. Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis. 1996;23(5):973-978. (Pubitemid 26367479)
9. Melsen WG, Rovers MM, Bonten MJM. Ventilator-associated pneumonia and mortality: a systematic review of observational studies. Crit Care Med. 2009;37(10):2709-2718.
10. Berra L, Curto F, Li Bassi G, et al. Antimicrobial-coated endotracheal tubes: an experimental study. Intensive Care Med. 2008;34(6):1020-1029. (Pubitemid 351903802)
11. Lai XZ, Feng Y, Pollard J, et al. Ceragenins: cholic acid-based mimics of antimicrobial peptides. Acc Chem Res. 2008;41(10):1233-1240.
12. Kolobow T, Berra L, Li Bassi G, Curto F. Novel system for complete removal of secretions within the endotracheal tube: the Mucus Shaver. Anesthesiology. 2005;102(5):1063-1065. (Pubitemid 40586550)
13. Resar R, Pronovost P, Haraden C, Simmonds T, Rainey T, Nolan T. Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. Jt Comm J Qual Patient Saf. 2005;31(5):243-248.
14. Zilberberg MD, Shorr AF, Kollef MH. Implementing quality improvements in the intensive care unit: ventilator bundle as an example. Crit Care Med. 2009;37(1):305-309.
15. Klompas M, Platt R. Ventilator-associated pneumonia - the wrong quality measure for benchmarking. Ann Intern Med. 2007;147(11):803-805. (Pubitemid 351664444)